{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:50:50Z","timestamp":1790668250992,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bulcan.2023.03.015","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T09:38:18Z","timestamp":1681378698000},"page":"707-730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recommandations conjointes du r\u00e9seau National ENDOCAN-COMETE, de l\u2019Association francophone de chirurgie endocrinienne et de la Soci\u00e9t\u00e9 fran\u00e7aise d\u2019urologie pour la prise en charge du carcinome corticosurr\u00e9nalien"],"prefix":"10.1016","volume":"110","author":[{"given":"Rossella","family":"Lib\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Haissaguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Renaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Faron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Decaussin-Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9deric","family":"Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Mirallie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Murez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Pattou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ta\u00efeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Henri","family":"Savoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"de la Fouchardi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2023.03.015_bib0470","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mce.2011.12.008","article-title":"Association of adrenocortical carcinoma with familial cancer susceptibility syndromes","volume":"351","author":"Else","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0475","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0480","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0485","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00261-018-1603-3","article-title":"Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography","volume":"43","author":"Thomas","year":"2018","journal-title":"Abdom Radiol N Y"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2020.01.012","article-title":"Radiomic mapping model for prediction of Ki-67 expression in adrenocortical carcinoma","volume":"75","author":"Ahmed","year":"2020","journal-title":"Clin Radiol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0495","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0500","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ejso.2017.06.009","article-title":"Needle tract seeding following core biopsies in retroperitoneal sarcoma","volume":"43","author":"Van Houdt","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0505","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/PAS.0b013e31825a6308","article-title":"Adrenocortical tumors: improving the practice of the Weiss system through virtual microscopy: a National Program of the French Network INCa-COMETE","volume":"36","author":"Tissier","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0510","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0515","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/106689690401200304","article-title":"Adrenocortical oncocytic tumors: report of 10 cases and review of the literature","volume":"12","author":"Bisceglia","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0520","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41379-018-0077-8","article-title":"Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation","volume":"3","author":"Renaudin","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.09.035","article-title":"Validation of the prognostic role of the \u201cHelsinki Score\u201d in 225 cases of adrenocortical carcinoma","volume":"62","author":"Duregon","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0530","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.humpath.2014.11.015","article-title":"Helsinki score\u00a0\u2013\u00a0a novel model for prediction of metastases in adrenocortical carcinomas","volume":"46","author":"Pennanen","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0535","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0b013e31828d387b","article-title":"The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished case","volume":"37","author":"Duregon","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0540","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAS.0000000000000943","article-title":"Diagnostic and prognostic biomarkers of adrenal cortical carcinoma","volume":"42","author":"Mete","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0545","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1078-0432.CCR-06-2085","article-title":"Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity","volume":"13","author":"Lib\u00e8","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0550","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.3390\/cancers14092225","article-title":"Screening for prognostic biomarkers in metastatic adrenocortical carcinoma by tissue micro arrays analysis identifies P53 as an independent prognostic marker of overall survival","volume":"14","author":"Hescot","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0555","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamaoncol.2019.1558","article-title":"Value of molecular classification for prognostic assessment of adrenocortical carcinoma","volume":"5","author":"Assi\u00e9","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0560","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): a European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Lib\u00e9","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0565","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0570","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ecl.2015.03.001","article-title":"Endocrine Tumor Board of Gustave Roussy. Adrenocortical carcinoma","volume":"44","author":"Baudin","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0575","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-21-0510","article-title":"S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study","volume":"186","author":"Elhassan","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0580","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0585","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","article-title":"Prognostic parameters of metastatic adrenocortical carcinoma","volume":"92","author":"Assi\u00e9","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0590","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2013.11.006","article-title":"Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer","volume":"65","author":"Berruti","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0595","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamasurg.2015.4516","article-title":"Nomograms to predict recurrence-free and overall survival after curative resection of adrenocortical carcinoma","volume":"151","author":"Kim","year":"2016","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.bulcan.2023.03.015_bib0605","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-21-1008","article-title":"Efficacy and tolerance of osilodrostat in patients with Cushing's syndrome due to adrenocortical carcinomas","volume":"186","author":"Tabarin","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0610","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2011-0536","article-title":"Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome","volume":"96","author":"Kamenick\u00fd","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bulcan.2023.03.015_bib0600","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/ERC-21-0202","article-title":"Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients","volume":"29","author":"Haberbosch","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0615","series-title":"Abs at ENDO Society, Atlanta","article-title":"Activity of Abiraterone Acetate in the management of Cushing syndrome associated to advanced adrenocortical carcinoma: results of the ABACUS trial","author":"Puglisi","year":"2022"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0620","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bjs.10414","article-title":"European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma","volume":"104","author":"Gaujoux","year":"2017","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.bulcan.2023.03.015_bib0625","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","article-title":"American Association of Endocrine Surgeons guidelines for adrenalectomy: executive summary","volume":"157","author":"Yip","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0630","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jamcollsurg.2015.12.013","article-title":"Outcomes of adjuvant mitotane after resection of adrenocortical carcinoma: a 13-institution study by the US Adrenocortical Carcinoma Group","volume":"222","author":"Postlewait","year":"2016","journal-title":"Am Coll Surg"},{"issue":"6","key":"10.1016\/j.bulcan.2023.03.015_bib0635","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00268-014-2484-4","article-title":"Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy","volume":"38","author":"Bednarski","year":"2014","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.bulcan.2023.03.015_bib0640","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1210\/jc.2019-00915","article-title":"National treatment practice for adrenocortical carcinoma: have they changed and have we made any progress?","volume":"104","author":"Tierney","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5\u20136","key":"10.1016\/j.bulcan.2023.03.015_bib0645","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ando.2019.09.001","article-title":"Adrenocortical carcinoma: impact of surgical treatment","volume":"80","author":"Miralli\u00e9","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"issue":"8","key":"10.1016\/j.bulcan.2023.03.015_bib0650","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1245\/s10434-018-6546-y","article-title":"Role of additional organ resection in adrenocortical carcinoma: analysis of 167 patients from the US Adrenocortical Carcinoma Database","volume":"25","author":"Marincola Smith","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0655","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00268-017-4290-2","article-title":"Minimally invasive adrenalectomy for adrenocortical carcinoma: five-year trends and predictors of conversion","volume":"42","author":"Calcatera","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0660","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1245\/s10434-015-4803-x","article-title":"Adrenocortical carcinoma: impact of surgical margin status on long-term outcomes","volume":"23","author":"Margonis","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0665","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1245\/s10434-020-08824-9","article-title":"Implications of conversion during attempted minimally invasive adrenalectomy for adrenocortical carcinoma","volume":"28","author":"Delozier","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0670","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2147\/OTT.S157518","article-title":"Open adrenalectomy versus laparoscopic adrenalectomy for adrenocortical carcinoma: a retrospective comparative study on short-term oncologic prognosis","volume":"11","author":"Zheng","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0675","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jso.26418","article-title":"Reassessing the impact of tumor size on operative approach in adrenocortical carcinoma","volume":"123","author":"Hue","year":"2021","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0680","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/SLA.0b013e3182367ac3","article-title":"Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma","volume":"255","author":"Reibetanz","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0685","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1245\/s10434-017-6064-3","article-title":"The impact of nodal dissection on staging in adrenocortical carcinoma","volume":"24","author":"Panjwani","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"Suppl. 5","key":"10.1016\/j.bulcan.2023.03.015_bib0690","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1245\/s10434-016-5536-1","article-title":"Lymphadenectomy for adrenocortical carcinoma: is there a therapeutic benefit?","volume":"23","author":"Gerry","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0695","series-title":"ECE","article-title":"Results of the ADIUVO trial, the first randomized study on adjuvant mitotane after removal of adrenocortical carcinoma","author":"Terzolo","year":"2020"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0700","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/jc.2010-2676","article-title":"Plasma concentrations of o,p\u2019DDD, o,p\u2019DDA, and o,p\u2019DDE aspredictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study","volume":"96","author":"Hermsen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0705","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2265.2011.04214.x","article-title":"Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma","volume":"75","author":"Kroiss","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0710","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.4158\/DSCR-2020-0567","article-title":"American Association of Clinical Endocrinology Disease State clinical review on the evaluation and management of adrenocortical carcinoma in an adult: a practical approach","volume":"26","author":"Kiseljak-Vassiliades","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0715","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/jpm11040269","article-title":"What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question","volume":"11","author":"Basile","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0720","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/cncr.24331","article-title":"Radiotherapy in adrenocortical carcinoma","volume":"115","author":"Polat","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0725","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1210\/jc.2006-1007","article-title":"Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma","volume":"91","author":"Fassnacht","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0730","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1210\/jc.2019-00029","article-title":"Adjuvant radiation improves recurrence-free survival and overall survival in adrenocortical carcinoma","volume":"104","author":"Gharzai","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0735","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1245\/s10434-018-6510-x","article-title":"Adjuvant radiation is associated with improved survival for select patients with non-metastatic adrenocortical carcinoma","volume":"25","author":"Nelson","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0740","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijrobp.2015.01.007","article-title":"Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma","volume":"92","author":"Sabolch","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0745","doi-asserted-by":"crossref","first-page":"e6741","DOI":"10.1097\/MD.0000000000006741","article-title":"The efficacy of radiation therapy in adrenocortical carcinoma: a propensity score analysis of a population-based study","volume":"96","author":"Luo","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0750","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1210\/jc.2012-2367","article-title":"A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma","volume":"98","author":"Habra","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0755","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.4103\/jcrt.JCRT_996_15","article-title":"Adjuvant radiotherapy after surgical resection for adrenocortical carcinoma: a systematic review of observational studies and meta-analysis","volume":"15","author":"Viani","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0760","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41416-021-01513-8","article-title":"Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study","volume":"125","author":"Kimpel","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0765","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1245\/s10434-015-4810-y","article-title":"Curative resection of adrenocortical carcinoma: rates and patterns of postoperative recurrence","volume":"23","author":"Amini","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0770","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1016\/j.purol.2019.01.011","article-title":"[French ccAFU guidelines\u00a0\u2013\u00a0Update 2018\u20132020: adrenal cancer]","volume":"28 Suppl. 1","author":"Savoie","year":"2018","journal-title":"Prog Urol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0775","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.surg.2016.08.058","article-title":"Surgery for recurrent adrenocortical carcinoma: a multicenter retrospective study","volume":"161","author":"Simon","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0780","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.surg.2018.04.068","article-title":"Longitudinal patterns of recurrence in patients with adrenocortical carcinoma","volume":"165","author":"Glenn","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0785","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/jc.2012-2559","article-title":"The role of surgery in the management of recurrent adrenocortical carcinoma","volume":"98","author":"Erdogan","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0790","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10434-999-0719-7","article-title":"Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma","volume":"6","author":"Schulick","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0795","doi-asserted-by":"crossref","first-page":"e4698","DOI":"10.1210\/clinem\/dgab449","article-title":"Combination of mitotane and locoregional treatments in low-volume metastatic adrenocortical carcinoma","volume":"106","author":"Boil\u00e8ve","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.bulcan.2023.03.015_bib0800","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.3390\/cancers14112730","article-title":"Loco-regional therapies in oligometastatic adrenocortical carcinoma","volume":"14","author":"Roux","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0805","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.surg.2007.09.006","article-title":"Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma","volume":"142","author":"Gonzalez","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0810","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1200\/JCO.1993.11.1.161","article-title":"Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study","volume":"11","author":"Bukowski","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0815","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/erc.1.01025","article-title":"Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial","volume":"12","author":"Berruti","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0820","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1677\/ERC-09-0341","article-title":"Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma","volume":"17","author":"Malandrino","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0825","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12672-017-0313-6","article-title":"Time until partial response in metastatic adrenocortical carcinoma long-term survivors","volume":"9","author":"Vezzosi","year":"2018","journal-title":"Horm Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0830","series-title":"SFE","article-title":"Valeurs pronostiques des mesures pr\u00e9coces de mitotan\u00e9mie plasmatique totale et libre ou au sein des fractions lipoprot\u00e9iques dans le corticosurr\u00e9nalome m\u00e9tastatique\u00a0: une \u00e9tude prospective du r\u00e9seau Com\u00e8te-Cancer","author":"Naman","year":"2020"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0835","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/PPO.0b013e31829e3221","article-title":"Role of radiotherapy in adrenocortical carcinoma","volume":"19","author":"Ho","year":"2013","journal-title":"Cancer J"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0840","doi-asserted-by":"crossref","first-page":"e80654","DOI":"10.1371\/journal.pone.0080654","article-title":"Treating adrenal tumors in 26 patients with CyberKnife: a mono-institutional experience","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0845","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0850","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1159::AID-CNCR28>3.0.CO;2-R","article-title":"Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study","volume":"88","author":"Williamson","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0855","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1210\/jc.2017-01624","article-title":"Gemcitabine-based chemotherapy in adrenocortical carcinoma: a multicenter study of efficacy and predictive factors","volume":"102","author":"Henning","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0860","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1677\/ERC-09-0281","article-title":"Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-\/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study","volume":"17","author":"Sperone","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0865","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/EJE-19-0570","article-title":"Activity and safety of temozolomide in advanced adrenocortical carcinoma patients","volume":"181","author":"Cosentini","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0870","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1210\/jc.2012-1419","article-title":"Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial","volume":"97","author":"Kroiss","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0875","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1210\/clinem\/dgz318","article-title":"Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib","volume":"105","author":"Kroiss","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0880","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s40425-018-0424-9","article-title":"Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial","volume":"6","author":"Le Tourneau","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0885","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s40425-019-0722-x","article-title":"Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma","volume":"7","author":"Habra","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0890","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1210\/jc.2019-00600","article-title":"Nivolumab in metastatic adrenocortical carcinoma: results of a phase 2 Trial","volume":"104","author":"Carneiro","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0895","series-title":"ESMO","article-title":"EO2401 (EO) therapeutic vaccine for patients (pts) with adrenocortical carcinoma (ACC) and malignant pheochromocytoma\/paraganglioma (MPP): phase I\/II SPENCER study","author":"Baudin","year":"2022"},{"issue":"4","key":"10.1016\/j.bulcan.2023.03.015_bib0900","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1470-2045(15)70081-1","article-title":"Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study","volume":"16","author":"Fassnacht","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0905","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11154-022-09769-y","article-title":"Pregnancy in patients with adrenocortical carcinoma: a case-based discussion","volume":"24","author":"Puglisi","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"10.1016\/j.bulcan.2023.03.015_bib0910","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1530\/EJE-10-0412","article-title":"Adrenocortical carcinoma and pregnancy: clinical and biological features and prognosis","volume":"163","author":"Abiven-Lepage","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0915","doi-asserted-by":"crossref","first-page":"E2238","DOI":"10.1210\/jc.2012-2374","article-title":"Targeting estrogen receptor-\u03b1 reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment","volume":"97","author":"Sirianni","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0920","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1210\/jc.2015-2341","article-title":"Pregnancy in women previously treated for an adrenocortical carcinoma","volume":"100","author":"de Corbi\u00e8re","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2023.03.015_bib0925","first-page":"186","article-title":"Pregnancy in a patient with adrenocortical carcinoma during treatment with Mitotane\u00a0\u2013\u00a0a case report","volume":"62","author":"Baszko-B\u0142aszyk","year":"2011","journal-title":"Endokrynol Pol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.03.015_bib0465","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/jc.2012-2839","article-title":"Pregnancy in a patient with adrenal carcinoma treated with mitotane: a case report and review of literature","volume":"98","author":"Tripto-Shkolnik","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123001558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123001558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:37:40Z","timestamp":1757792260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455123001558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0007455123001558"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.03.015","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommandations conjointes du r\u00e9seau National ENDOCAN-COMETE, de l\u2019Association francophone de chirurgie endocrinienne et de la Soci\u00e9t\u00e9 fran\u00e7aise d\u2019urologie pour la prise en charge du carcinome corticosurr\u00e9nalien","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}